News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer
Ovarian Cancer
Feb 1, 2025, 16:18

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared an article by Jeffrey Bell, et al. on X:

“Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian cancer:

GOG 157: 3 cycles of chemo may be sufficient for high risk early stage EOC.”

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Authors: Jeffrey Bell, et al.

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

cancer carboplatin EOC fight against cancer Global fight against cancer MVR Cancer Centre and Research Institute OncoDaily Oncology Ovarian Cancer Paclitaxel
Special Coverage
Blog
Jun 5, 2025, 11:38
Vincent Rajkumar: Photo of the year for Myeloma, Cilta-cel in Multi-Drug Refractory Disease
Blog
Jun 5, 2025, 11:37
Shannon Westin Spotlights Jason Westin's Advocacy Master Class at ASCO 2025 Annual Meeting
Blog
Jun 5, 2025, 11:31
Publication 101: Peer Review and Becoming a Successful Author - Journal of Clinical Oncology
Opinion
Jun 5, 2025, 11:24
Jason A. Mouabbi: Non-Pharmacologic Insights from ASCO25 - Two of the Most Provocative Findings
Blog
Jun 5, 2025, 11:21
EIOC Shares Commentary and Results from IMforte Trial in Small Cell Lung Cancer
Blog
Jun 5, 2025, 11:07
Join the 2nd National Cancer Summit for Worldwide Insights on Cancer Control in Kenya - National Cancer Institute of Kenya
Blog
Jun 5, 2025, 11:02
Gevorg Tamamyan: Honored to Join Asya Agulnik as Co-Chair of the St. Jude EURO Regional Advisory Committee
Science
Jun 5, 2025, 10:57
Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO
Science
Jun 5, 2025, 10:49
Incidence and Survival Outcomes of Breast Cancer Subtypes in the United States
Blog
Jun 5, 2025, 10:48
Tian Zhang: Leaving Chicago and ASCO25 with Full Heart – Data, Mentorship, and Cancer Research
Blog
Jun 5, 2025, 10:34
Vivek Subbiah: Sharing the Key advances in Oncology and Exciting Publications from ASCO25
Blog
Jun 5, 2025, 10:31
National Cancer Institute of Kenya at 2025 ASCO Annual Meeting